Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
RecycLiCo’s U.S. Subsidiary and Alaska Energy Metals Corporation Enter Memorandum of Understanding to Advance Goal of Creating Domestic Critical Metal Supply Chain
